7 November 2024

New Musculoskeletal service set to transform care for patients in Sussex

by

Image of a woman with her foot on a practitioners knee receiving MSK treatment

New Musculoskeletal service set to transform care for patients in Sussex

 

“We are delighted to be awarded this contract along with SCFT as part of an innovative new Sussex MSK collaborative. Working closely with partners, professionals, patients, and our communities, this collaboration builds on our long-standing set of innovations that are leading the way nationally in how MSK healthcare is delivered. This marks another significant step on our journey to deliver exceptional care for those we serve. 

Our vision is to deliver the highest standards of patient care by providing equitable, personalised, and seamless services across the entire MSK pathway.” ~ Helen Curr, chief executive officer at Here.

 

Health and care partners across Sussex are delighted to announce that an innovative new Musculoskeletal (MSK) service is set to start for local people in December 2024.  

This is the culmination of four years of work and engagement with many stakeholders across the Sussex health and care system to design a transformed, integrated, MSK service for patients in Sussex.    

Following a robust procurement process, Sussex Community NHS Foundation Trust, working alongside University Hospitals Sussex NHS Foundation Trust and Here, have been awarded a new contract to deliver MSK services in West Sussex and Brighton and Hove; and East Sussex Healthcare NHS Trust, working alongside Horder Healthcare will cover East Sussex.  

The approach taken across Sussex is considered national best practice and is clear in its ambition to improve care and experience for local people.   

The new service will see a fully integrated MSK pathway across primary, community and secondary care for orthopaedics, pain and rheumatology, and include services such as physiotherapy, diagnostics, and surgical treatment.   

The new service will focus on improving access, experience, and outcomes for patients, with providers working together to ensure patients receive a consistent experience, feel supported throughout the whole pathway, and get the best treatment first time.   

Other planned improvements to Sussex MSK services, under this new contract, are: 

  • Better communication and information for patients to empower them to be in-charge of their own care and make informed choices about treatment options 
  • A more joined-up and coordinated care offering which breaks-down traditional barriers between organisations 
  • Streamlining access to care and advice: providing much more choice about how people can access care, and that services are available in their community when they need them 
  • Helping people to live and work well for longer and offer more personalised care, including supported self-management when they need it, via digital platforms   
  • A more concerted and systematic approach to reducing health inequalities and addressing variation in terms of access, waiting times and service provision.   
  • Offering a personalised model of delivery for outpatient appointments, including virtual appointments where clinically and personally appropriate (considering other factors relevant to the individual) and face-to-face appointments. 

The new service’s specification is fully aligned to Sussex’s five year health and care strategy, Improving Lives Together, by working to a new, joined-up, community-based approach to MSK care, by growing and developing the Sussex health and care workforce, by improving the use digital technology and information, and by maximising the power of partnership working across health and care organisations in Sussex.   

The specification and awarding of the successful bid were developed with a range of different partners, including patient representatives and Healthwatch. The service contract is worth around £41m per year of the contract – which is for five years, with the option of two additional years after the initial five.  

MSK conditions can affect joints, bones and muscles and sometimes associated tissues such as nerves. They can range from minor injuries to long-term conditions.

Over 20 million people in the UK, almost one third of the population, have a MSK condition such as arthritis or back pain.

Symptoms can include pain, stiffness, limited movement, and disability which affect quality of life and independence. 

In Sussex, MSK services are in high demand, so the new service is an important step for providing quality services for local people. For example, in 2019-20, over 172,000 referrals were made to MSK services, which resulted in 225,000 community appointments and 67,000 referrals on to secondary care.

Work is taking place at pace to implement changes which are required to develop the new service, which is due to go live on 1 December 2024.

Also of interest

Reflecting on a decade of impact: A farewell to Sussex MSK Partnership Central

Reflecting on a decade of impact: A farewell to Sussex MSK Partnership Central

As we approach the conclusion of the Sussex MSK Partnership Central (SMSKPC) service, we’re taking a moment to celebrate the extraordinary journey we’ve shared. Over the past decade, this partnership has been more than a service – it’s been a community, a purpose, and a shared commitment to making a real difference in people’s lives.

read more
World Stroke Day 2024: Alasdair’s story of recovery

World Stroke Day 2024: Alasdair’s story of recovery

This World Stroke Day we wanted to share Alasdair’s story. In this video stroke survivor Alasdair and his wife Emma talk about their experience of what it was like to be invited to be a part of the Stroke Health and Wellbeing Service, and the difference this support had on Alasdair’s recovery to date.

read more